Evolve Business Intelligence has released a new market research report on Global White Biotechnology Market by Product Type (Biochemical, Biofuel, Biomaterial, Bioproduct), by Application (Food & Feed, Pharmaceutical, Pulp & Paper, Textile, Energy, Other) and by Commodity Type (Grains and starch crops, agricultural residues, food waste, forest material, animal by-products, energy crops, urban and suburban waste) and by geography – COVID-19 Impact Analysis, Post-COVID Analysis, Opportunities, Trends and Forecast from 2022 to 2032
The global white biotechnology market size is forecast to grow at a CAGR of approximately 6% from 2022 to 2032. The future of the biotechnology market is bright. Red biotechnology products are still the most widespread type of medicines. However, growing concerns about terminal diseases such as cancer and emphasis on patient comfort and convenience are expected to drive the market growth soon.
Request a free sample report or PDF copy: https://report.evolvebi.com/index.php/sample/request?referer=parity&reportCode=015628
The White Biotechnology market report provides detailed information about the company and its performance to date. This will give you a clear picture of how strong an industry is, what kind of wealth comes with it, and which areas are growing over time. Every single element in a market report is updated regularly to help us read the market better. The report also includes general risks associated with marketing in such a delicate industry as it offers advice for future planning of a related business expansion.
The key players profiled in the report are:
• Archer Daniels Midland Company
• BASF SE
• Corbion NV
• Royal DSM NV
• Fujifilm Holdings Corporation
• GE Healthcare
• Hitachi Medical Corporation
• Hologic, Inc.
• iCAD, Inc.
• InVivo Corporation
• McKesson Corporation
• Merge of Healthcare Incorporated (IBM)
• Philips Healthcare